Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug Last Updated : Jun 06 2024 | 3:31 PM IST |
Indoco Remedies added 2.68% to Rs 317.55 after the company has received tentative approval from the US Food and Drug
administration (USFDA) for its abbreviated new drug application (ANDA) for canagliflozin and metformin tablets. Aditi Panandikar, managing director said, We are excited to receive the tentative approval from the USFDA for our Canagliflozin and Metformin Hydrochloride
Tablets. This milestone underscores our commitment to bringing affordable and effective treatment options to patients managing type 2 diabetes. Powered by Capital Market - Live News |
|